Vivo Capital
Biotech Investor · 5 portfolio companies
Portfolio
5
Combined Value
$71.5M
Focus Areas
10
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| PMV Pharmaceuticals | $71.5M |
| Magnolia Medical Technologies | — |
| Ossium Health | — |
| APRINOIA Therapeutics | — |
| InnoCare | — |